
Miriam E. Tucker
Contributing Writer at Medscape
Contributing Writer at The Washington Post
Contributing Writer at Freelance
Writer/journalist specializing in medicine/health. Living with type 1 diabetes since 1973.
Articles
-
1 week ago |
medscape.com | Miriam E. Tucker
An international expert panel has recently released a comprehensive set of recommendations for optimal insulin injection techniques and equipment. The group, called the Forum for Injection Technique and Therapy Expert Recommendations (FITTER), last issued recommendations for insulin injection practices in 2016.
-
2 weeks ago |
deutsch.medscape.com | Miriam E. Tucker
close Sind Sie sicher, dass Sie sich ausloggen wollen? Malaga – Eine neue Studie, die auf dem diesjährigen Europäischen Adipositas-Kongress (European Congress on Obesity, 11.-14. Mai 2025 in Málaga) vorgestellt wird, liefert vielversprechende Ergebnisse zur Wirkung moderner Adipositas-Medikamente.
-
2 weeks ago |
medscape.com | Miriam E. Tucker
The “4S Pathway” offers strategies for realigning treatment goals and approaches for older adults with type 1 diabetes (T1D) or type 2 diabetes (T2D) who are struggling with self-management. Worldwide, more than 20% of people aged 65 years or older have diabetes. This population is very diverse; while some individuals successfully manage their diabetes as they age, others face cognitive and physical challenges that impede self-management.
-
3 weeks ago |
portugues.medscape.com | Miriam E. Tucker
O diabetes relacionado com a desnutrição, diferente do diabetes tipo 1 e tipo 2, agora foi oficialmente reconhecido e denominado “diabetes tipo 5”. A votação para endossar a categoria ocorreu em 08 de abril, durante o International Diabetes Federation’s World Diabetes Congress em Bangkok, na Tailândia. Em janeiro de 2025, um grupo de especialistas se reuniu na Índia para redigir uma declaração de consenso sobre a doença, a ser publicada em breve, disse ao Medscape a médica Dra.
-
3 weeks ago |
medscape.com | Miriam E. Tucker
New data documented dramatic shifts in prescribing for both type 2 diabetes (T2D) and weight loss, particularly with the uptake of tirzepatide (Lilly) and declines in the use of older agents.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 10K
- Tweets
- 31K
- DMs Open
- Yes

RT @DrNeilStone: I never intended to use my X account to combat medical disinformation and misinformation. Just happened gradually. And t…

RT @DrNeilStone: My whole career as a doctor and scientist in the UK I used to look "across the pond" to the US as the world leader in scie…

Ha, that I didn't know.

He blocks with such frequency that at height of the pandemic there was even a hashtag #blockedbyvinay